A pharmacological study of UK-18,892 and amikacin.
D000328:Adult; D000583:Amikacin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000378:metabolism*; D006207:Half-Life; D006801:Humans; D007612:Kanamycin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000378:metabolism; D008297:Male
D007612:Kanamycin; D000583:Amikacin